首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Endocrinologia diabetes y nutricion

缩写:ENDOCRINOL DIAB NUTR

ISSN:2530-0180

e-ISSN:2530-0180

IF/分区:1.8/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1001
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
José-Joaquín Alfaro-Martínez,David Primo-Martín,César Gonzalvo-Díaz et al. José-Joaquín Alfaro-Martínez et al.
Background: Rapid weight loss with restricted diets can cause muscle mass decline. The aim of this work is to evaluate a new method for representing the raw electrical values obtained in the bioelectrical impedance analys...
Ignacio Jiménez Hernando,Irene Bretón Lesmes,Arantxa Díaz Gómez et al. Ignacio Jiménez Hernando et al.
Estrella Diego,María Del Carmen Farnández,Beatriz de León et al. Estrella Diego et al.
Introduction: Multivitamin preparations with added vitamin K in parenteral nutrition (PN) ensure the coverage of this micronutrient in all adults, as indicated by the latest ESPEN clinical practice guidelines on micronutr...
Irene Breton,Igotz Aranbarri,Anastasia Lampropoulou et al. Irene Breton et al.
Introduction: The epIdeMiology landscape PAtient Care paThways of Obesity (IMPACT-O) study was a multi-country, retrospective cohort study that utilised healthcare databases to determine the landscape/impact of overweight...
Beyza Olcay Ozturk,Umran Keskin,Serhat Uysal et al. Beyza Olcay Ozturk et al.
Purpose: Despite several factors are associated with worse disease-free survival (DFS) and prognosis in medullary thyroid carcinoma (MTC) patients, the effect of microscopic extrathyroidal extension (mETE) on the prognosi...
María Carmen Dameto Pons,Elena González Arnáiz,María Antequera González et al. María Carmen Dameto Pons et al.
Immunotherapy is an increasingly used treatment for different types of cancer. The most widely used are cytotoxic T-lymphocyte antigen 4 (CTLA-4) inhibitors, PD-1 ligand (PD-L1) inhibitors and PD-1 receptor inhibitors. All of them can produ...